Jennerex names new vice president of corporate development

Ms Miller has held senior positions in business development, including the title of vice president, in various companies including Anesiva, Theravance, Scios Pharmaceuticals, Onyx Pharmaceuticals and Procter & Gamble Pharmaceuticals.

David Kirn, president and CEO of Jennerex, said: “Samantha is an outstanding addition to our executive management team. As Jennerex continues to report compelling Phase I and II clinical data from its oncology programs, Samantha joins us at an opportune time for the development of additional strategic partnerships.

“We have clear regulatory pathways to large global cancer markets with multiple products, and Samantha’s addition to the Jennerex team further endorses the potential of the company’s product platform.”